3/2
04:05 pm
cadl
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/24
08:33 am
cadl
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston [Yahoo! Finance]
Low
Report
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston [Yahoo! Finance]
2/24
08:05 am
cadl
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
Low
Report
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
2/19
09:40 pm
cadl
Candel Therapeutics Announces Pricing of Public Offering
Low
Report
Candel Therapeutics Announces Pricing of Public Offering
2/19
04:53 pm
cadl
Candel Therapeutics inks $100M funding agreement with RTW Investments, launches $100M public offering [Yahoo! Finance]
Medium
Report
Candel Therapeutics inks $100M funding agreement with RTW Investments, launches $100M public offering [Yahoo! Finance]
2/19
04:05 pm
cadl
Candel Therapeutics Announces Proposed $100 Million Public Offering
Low
Report
Candel Therapeutics Announces Proposed $100 Million Public Offering
2/19
04:01 pm
cadl
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
High
Report
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
2/11
08:53 am
cadl
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit [Yahoo! Finance]
Medium
Report
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit [Yahoo! Finance]
2/11
08:05 am
cadl
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
Medium
Report
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
2/4
06:00 pm
cadl
Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight [Yahoo! Finance]
Medium
Report
Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight [Yahoo! Finance]
2/2
04:21 pm
cadl
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
2/2
04:05 pm
cadl
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/14
07:11 pm
cadl
Loss-Making Candel Therapeutics, Inc. (NASDAQ:CADL) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Medium
Report
Loss-Making Candel Therapeutics, Inc. (NASDAQ:CADL) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
12/8
09:00 am
cadl
Candel Therapeutics (NASDAQ:CADL) had its "overweight" rating reaffirmed by analysts at Stephens. They now have a $15.00 price target on the stock.
Low
Report
Candel Therapeutics (NASDAQ:CADL) had its "overweight" rating reaffirmed by analysts at Stephens. They now have a $15.00 price target on the stock.